Novocuff, Inc.

About Novocuff, Inc.

Novocuff, Inc. is a medical device company focused on improving outcomes for pregnancies affected by preterm premature rupture of membranes (PPROM) and cervical shortening. Their mission is to address these conditions to extend pregnancy duration and reduce prematurity.

Products & Services

Novocuff Cervical Control System (CCS):A medical device designed to support and close the cervix to retain amniotic fluid in patients with PPROM and sustain cervical length in patients with cervical shortening, aiming to extend pregnancy and reduce prematurity. Currently an investigational device limited to investigational use in the United States.

Specialties

Preterm birth prevention Medical devices for pregnancy complications Management of PPROM and cervical shortening

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 26000000 MR: - FA: $26 million FAN: 26000000	D: 2024-07-17 FD: 2024-07-17	6 investors

Series A Latest

2024-07-17

$26.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Amelia Degenkolb

Ferolyn Fellow

L

Lisa Tehrani

Director of Marketing

R

Ross McQuivey

Medical Advisor

D

Donald Lee

COO & Co-Founder

M

Marissa VanDeVeer

Clinical Engineer

K

Kathryn Wine

VP of Clinical Affairs

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Novocuff, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised